Epilepsy researcher Sujithra Srinivas discusses the value of translational research for understanding and treating neurologic ...

Experts warn federal spending cuts will make the country sicker and poorer as healthcare costs rise without new treatments.

Christopher Kuehl, the Company's current Chief Investment Officer, will assume the newly created role of Head of Investment Research and ... significant advances in financial technology and ...

Epilepsy, a neurological disorder affecting ... solutions and a member of Polyrizon’s Scientific Advisory Board. The research will evaluate the drug loading capacity, release kinetics, nasal ...

In 2023, global cannabis sales were estimated at $32 billion, with North America dominating over 75% of total revenue due to widespread legalization in the U.S. and Canada. However, international ...

He leads a large translational research team undertaking both basic studies and clinical studies focused on developing improved treatments for people with epilepsy and related brain diseases ...

We recently published a list of 12 High Growth Low Debt Stocks to Invest in Now. In this article, we are going to take a look ...

Security incidents affecting financial institutions are becoming increasingly common, whether they involve banks, fintech companies or investment research firms. The latest case involves Zacks ...

Bajaj Healthcare’s stock has surged, fuelled by regulatory approvals and expansion into high-growth markets. But with a ...

WACC (Weighted Average Cost of Capital): 11.05%, coming from 11.5% cost of equity (about 11% I use for a no-moat stock, but I ...